Cargando…

Paclitaxel: new uses for an old drug

Paclitaxel (Taxol), one of the most important anticancer drugs, has been used for therapy of different types of cancers. Mechanistically, paclitaxel arrests cell cycle and induces cell death by stabilizing microtubules and interfering with microtubule disassembly in cell division. Recently, it has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dongshan, Yang, Ruhao, Wang, Shixuan, Dong, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934593/
https://www.ncbi.nlm.nih.gov/pubmed/24591817
http://dx.doi.org/10.2147/DDDT.S56801
_version_ 1782305075477086208
author Zhang, Dongshan
Yang, Ruhao
Wang, Shixuan
Dong, Zheng
author_facet Zhang, Dongshan
Yang, Ruhao
Wang, Shixuan
Dong, Zheng
author_sort Zhang, Dongshan
collection PubMed
description Paclitaxel (Taxol), one of the most important anticancer drugs, has been used for therapy of different types of cancers. Mechanistically, paclitaxel arrests cell cycle and induces cell death by stabilizing microtubules and interfering with microtubule disassembly in cell division. Recently, it has been found that low-dose paclitaxel seems promising in treating non-cancer diseases, such as skin disorders, renal and hepatic fibrosis, inflammation, axon regeneration, limb salvage, and coronary artery restenosis. Future studies need to understand the mechanisms underlying these effects in order to design therapies with specificity.
format Online
Article
Text
id pubmed-3934593
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-39345932014-03-03 Paclitaxel: new uses for an old drug Zhang, Dongshan Yang, Ruhao Wang, Shixuan Dong, Zheng Drug Des Devel Ther Perspectives Paclitaxel (Taxol), one of the most important anticancer drugs, has been used for therapy of different types of cancers. Mechanistically, paclitaxel arrests cell cycle and induces cell death by stabilizing microtubules and interfering with microtubule disassembly in cell division. Recently, it has been found that low-dose paclitaxel seems promising in treating non-cancer diseases, such as skin disorders, renal and hepatic fibrosis, inflammation, axon regeneration, limb salvage, and coronary artery restenosis. Future studies need to understand the mechanisms underlying these effects in order to design therapies with specificity. Dove Medical Press 2014-02-20 /pmc/articles/PMC3934593/ /pubmed/24591817 http://dx.doi.org/10.2147/DDDT.S56801 Text en © 2014 Zhang et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Perspectives
Zhang, Dongshan
Yang, Ruhao
Wang, Shixuan
Dong, Zheng
Paclitaxel: new uses for an old drug
title Paclitaxel: new uses for an old drug
title_full Paclitaxel: new uses for an old drug
title_fullStr Paclitaxel: new uses for an old drug
title_full_unstemmed Paclitaxel: new uses for an old drug
title_short Paclitaxel: new uses for an old drug
title_sort paclitaxel: new uses for an old drug
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934593/
https://www.ncbi.nlm.nih.gov/pubmed/24591817
http://dx.doi.org/10.2147/DDDT.S56801
work_keys_str_mv AT zhangdongshan paclitaxelnewusesforanolddrug
AT yangruhao paclitaxelnewusesforanolddrug
AT wangshixuan paclitaxelnewusesforanolddrug
AT dongzheng paclitaxelnewusesforanolddrug